Recent Updates
Recently added Catalysts
DXCM Positive Sentiment

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Key Takeaway: Dexcom, Inc. has announced the release date for its second quarter 2026 financial results, which will occur after market close on July 30, 2026. Following the release, management will conduct a conference call at 4:30 p.m. Eastern Time to discuss the company's performance. The call will also be available via webcast.
Price reaction · baseline $74.06 (2026-07-08 close) · hit pre-market · clean, no other DXCM news in the window
day 0 close · peak
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dexcom is actively engaging with investors through earnings release.
  • The scheduled conference call indicates transparency in financial performance.
  • The webcast allows broader access to financial information.

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will

Frequently Asked Questions

When will Dexcom release its Q2 2026 financial results?

Dexcom plans to release its Q2 2026 financial results on July 30, 2026.

What time is the Dexcom Q2 2026 conference call?

The conference call will start at 4:30 p.m. Eastern Time on July 30, 2026.

Where can I access the Dexcom conference call webcast?

The webcast link will be available on the Dexcom investor relations website.

What is the purpose of the Dexcom conference call?

The call will review the company's performance for the second quarter of 2026.

Last updated: Jul 9, 2026